Current Value of Holding

$16.5 Million

Shares

18.2 Thousand

% of Portfolio

0.13%

Average Buy Price

$506

Avg closing price
Price range

26 Cathie Wood Regeneron Pharmaceuticals Trades

Cathie Wood acquired 18.2 Thousand Regeneron Pharmaceuticals shares worth $16.5 Million. That's 0.13% of their equity portfolio (81st largest holding). The first Regeneron Pharmaceuticals trade was made in Q4 2016. Since then Cathie Wood bought shares nine more times and sold shares on sixteen occasions. The stake costed the investor $9.22 Million, netting the investor a gain of 79% so far.

Avg closing price
Price range
Sold 34.3% shares (-9.52 Thousand shares) Q1 2024
Avg closing price $950.88
Price range $902.69 - $993.35
Sold 0.0% shares (-9 shares) Q4 2023
Avg closing price $823.50
Price range $775.18 - $881.70
Sold 14.0% shares (-4.51 Thousand shares) Q3 2023
Avg closing price $785.91
Price range $692.45 - $844.37
Sold 4.0% shares (-1.34 Thousand shares) Q2 2023
Avg closing price $771.00
Price range $700.03 - $830.35
Sold 1.4% shares (-462 shares) Q1 2023
Avg closing price $754.21
Price range $680.49 - $826.97
Sold 7.8% shares (-2.89 Thousand shares) Q4 2022
Avg closing price $737.86
Price range $705.89 - $766.39
Sold 33.8% shares (-18.9 Thousand shares) Q3 2022
Avg closing price $629.39
Price range $573.97 - $724.32
Sold 3.4% shares (-1.96 Thousand shares) Q2 2022
Avg closing price $650.01
Price range $548.35 - $738.84
Sold 20.9% shares (-15.2 Thousand shares) Q1 2022
Avg closing price $632.65
Price range $595.12 - $698.43
Sold 83.0% shares (-355 Thousand shares) Q4 2021
Avg closing price $614.83
Price range $543.48 - $670.97
Sold 40.0% shares (-285 Thousand shares) Q3 2021
Avg closing price $620.82
Price range $574.03 - $680.96
Sold 41.5% shares (-506 Thousand shares) Q2 2021
Avg closing price $506.62
Price range $472.80 - $558.54
Increased shares by 169.8% (+767 Thousand shares) Q1 2021
Avg closing price $486.87
Price range $446.73 - $548.20
New holding (+452 Thousand shares) Q4 2020
Avg closing price $539.80
Price range $478.30 - $607.98
Sold -89 shares Q2 2020
Avg closing price $567.62
Price range $493.32 - $643.92
Sold 99.3% shares (-13.1 Thousand shares) Q4 2019
Avg closing price $336.44
Price range $274.13 - $376.51
Sold 4.9% shares (-684 shares) Q1 2019
Avg closing price $411.79
Price range $372.08 - $439.57
Sold 40.1% shares (-9.32 Thousand shares) Q4 2018
Avg closing price $366.02
Price range $335.82 - $403.04
Increased shares by 25.1% (+4.66 Thousand shares) Q3 2018
Avg closing price $380.58
Price range $351.14 - $408.51
Increased shares by 458.9% (+15.3 Thousand shares) Q2 2018
Avg closing price $312.75
Price range $284.60 - $344.99

News about Regeneron Pharmaceuticals, Inc. and Cathie Wood

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!